Literature DB >> 11339973

Role of 5-HT(2C) receptors in the control of central dopamine function.

V Di Matteo1, A De Blasi, C Di Giulio, E Esposito.   

Abstract

Substantial evidence suggests that the functional status of the mesocorticolimbic dopamine (DA) system originating in the ventral tegmental area is under a phasic and tonic inhibitory control by the 5-HT system that acts by stimulating 5-HT(2C) receptor subtypes. Indeed, electrophysiological and biochemical data demonstrate that 5-HT(2C) receptor agonists decrease, whereas 5-HT(2C) receptor antagonists enhance, mesocorticolimbic DA function. However, 5-HT(2C) receptors do not appear to play a relevant role in the control of the nigrostriatal DA system originating in the substantia nigra pars compacta. In this article, the role of 5-HT(2C) receptors in the control of brain DA function will be reviewed, and the search for new therapies for neuropsychiatric disorders, such as depression, schizophrenia and drug addiction, based on these findings will be discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11339973     DOI: 10.1016/s0165-6147(00)01688-6

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  55 in total

1.  Synaptic multiprotein complexes associated with 5-HT(2C) receptors: a proteomic approach.

Authors:  Carine Bécamel; Gérard Alonso; Nathalie Galéotti; Emmanuelle Demey; Patrick Jouin; Christoph Ullmer; Aline Dumuis; Joël Bockaert; Philippe Marin
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

2.  Role of serotonin in cocaine effects in mice with reduced dopamine transporter function.

Authors:  Yolanda Mateo; Evgeny A Budygin; Carrie E John; Sara R Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

3.  Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the rat.

Authors:  Michael H Baumann; Zakia Williams; Dorota Zolkowska; Richard B Rothman
Journal:  Drug Alcohol Depend       Date:  2010-11-10       Impact factor: 4.492

Review 4.  Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia.

Authors:  Jiri Horacek; Vera Bubenikova-Valesova; Milan Kopecek; Tomas Palenicek; Colleen Dockery; Pavel Mohr; Cyril Höschl
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 5.  Serotonin2C receptors and drug addiction: focus on cocaine.

Authors:  Céline Devroye; Malgorzata Filip; Edmund Przegaliński; Andrew C McCreary; Umberto Spampinato
Journal:  Exp Brain Res       Date:  2013-06-08       Impact factor: 1.972

6.  Dorsal raphe neurons signal reward through 5-HT and glutamate.

Authors:  Zhixiang Liu; Jingfeng Zhou; Yi Li; Fei Hu; Yao Lu; Ming Ma; Qiru Feng; Ju-En Zhang; Daqing Wang; Jiawei Zeng; Junhong Bao; Ji-Young Kim; Zhou-Feng Chen; Salah El Mestikawy; Minmin Luo
Journal:  Neuron       Date:  2014-03-19       Impact factor: 17.173

7.  Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex.

Authors:  C Nocjar; K D Alex; A Sonneborn; A I Abbas; B L Roth; E A Pehek
Journal:  Neuroscience       Date:  2015-03-27       Impact factor: 3.590

Review 8.  Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.

Authors:  P De Deurwaerdère; M Lagière; M Bosc; S Navailles
Journal:  Exp Brain Res       Date:  2013-04-25       Impact factor: 1.972

9.  Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat.

Authors:  Samantha L McLean; Marie L Woolley; Dave Thomas; Joanna C Neill
Journal:  Psychopharmacology (Berl)       Date:  2009-07-21       Impact factor: 4.530

10.  Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.

Authors:  Mark J Millan; Sylvie Veiga; Sylvie Girardon; Mauricette Brocco
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.